Articles tagged with Organ Transplantation
A study found that pediatric transplant patients attend on average less than one appointment per year after transferring to adult care, resulting in longer hospital stays and poorer health outcomes. Maintaining regular appointments is crucial for continued transplant success, according to the researchers.
Researchers aim to improve pediatric heart transplant outcomes by identifying how certain drugs work and developing new medications to prevent damage to transplanted hearts. The studies will focus on a recently identified population of immune cells, MAIT cells, to adjust medication dosages and minimize side effects.
A study of 309 people with long COVID found that fatigue, shortness of breath, and loss of sense of smell were the most persistent symptoms. The research also revealed that factors such as history of hospitalization, diabetes, and body mass index increased the risk of developing Long COVID.
A new study found that Black kidney transplant recipients exhibit a faster clearance rate of tacrolimus, an immunosuppressive drug. The study suggests that considering both sex and race when dosing tacrolimus may reduce adverse effects and enhance transplant outcomes.
Researchers at Stevens Institute of Technology are pushing through technical barriers in organ printing by leveraging decades-old technique and computational modeling. The team aims to create any type of organ at any time, including skin on an open wound, using microfluidic bio-printing.
A new study shows that three doses of mRNA vaccine provide substantially greater protection against severe COVID-19 for immunosuppressed transplant patients. Boosters appear to increase effectiveness, with a regimen of two doses only 29% effective and three doses 77% effective in preventing hospitalization.
The European Society of Clinical Microbiology and Infectious Diseases finds organ donation from COVID-19 patients is safe and does not transmit SARS-CoV-2. Recipients with asymptomatic infections are also now eligible for transplant, but must be triple-vaccinated.
Organ donation from dying COVID-19 patients appears to be safe and does not infect recipients with SARS-CoV-2. The study found all 6 abdominal organs had stable graft function and no unexpected rejection occurred.
Research in the Journal of Hepatology suggests that COVID-19 vaccines are unlikely to cause liver injury, but liver transplant patients may experience delayed care due to the pandemic. The study found that vaccinated patients with liver disease had a lower antibody response compared to healthy patients.
The American Society of Transplant Surgeons' COVID-19 Strike Force recommends vaccinating patients on the organ transplant waiting list. This move aims to improve patient safety and reduce transmission risks during the pandemic.
A cost-effectiveness analysis found that adherence promotion programs like MAPS reduce costs and improve outcomes for adolescent kidney transplant recipients. Strategies with similar costs to MAPS can still be cost-effective if they decrease rejection episodes by a small amount.
Young adults are disproportionately excluded from kidney transplantation, with only 1.8% of Black and 4.4% of Hispanic patients receiving the treatment compared to 10.9% of White patients within this age group. The study highlights the need for targeted interventions to address these disparities.
A human polyomavirus (HPyV9) has been identified as a cause of severe skin rash and subsequent organ failure in solid organ transplant recipients. Routine testing for the virus is now recommended to prevent such cases, with the use of a new technique called VirCapSeq-VERT.
A team of researchers at Kumamoto University successfully created complex 3D kidney tissue in the lab using mouse embryonic stem cells. The breakthrough could lead to advances in kidney research and potentially even transplantable organs.
A new study aims to improve antibody responses in kidney and liver transplant recipients to COVID-19 mRNA vaccine doses, exploring the impact of reduced immunosuppressive medication. The CPAT-ISR trial will enroll up to 400 adults with a history of organ transplants and evaluate the effectiveness of this strategy.
Researchers at Johns Hopkins Medicine have successfully transplanted a kidney from a COVID-19 donor, demonstrating that healthy kidneys from such donors can be safely transplanted. The recipient has shown no signs or symptoms of the virus and has excellent kidney function since the transplant.
Scientists have discovered families of proteins that can predict liver transplant rejection, allowing for early detection and modification of immunosuppression. The Blood Proteoform Atlas outlines over 56,000 protein molecules associated with immune cell proteins that change with rejection.
A national analysis of lung transplantations performed in the US between August 2020 and September 2021 shows that 7% of lung transplants were performed to treat COVID-19-related lung damage. The study suggests that lung transplantation may be a safe option for select patients with severe, irreversible lung damage.
UAB surgeons successfully transplanted a genetically modified pig kidney into a brain-dead human recipient, testing safety and feasibility in a novel human preclinical model. The experiment showed that the xenograft perfused normally and maintained vascular integrity, paving the way for potential treatment of thousands with organ failu...
Researchers at UAB successfully transplanted genetically modified pig kidneys into a brain-dead human, demonstrating the feasibility of xenotransplantation. The kidneys functioned for 77 hours without immediate rejection, paving the way for potential treatment of thousands suffering from kidney failure.
A recent study published in Transplantation Direct highlights the increased risk of death from cancer and infection for kidney transplant patients. Focusing on lifestyle changes such as weight loss, exercise, and diabetes management can improve long-term outcomes for these patients.
A recent study found that the number of stage 3 AKI kidneys transplanted in the US has increased significantly over the last decade, yet 44% are still discarded. This highlights the need for further efforts to optimize the use of these organs and reduce waste.
Researchers have developed a highly sensitive immuno-CRISPR assay to detect acute kidney rejection in urine, potentially allowing for early diagnosis without invasive biopsy. The test uses CRISPR/Cas12a gene editing technology to identify biomarkers of rejection, such as CXCL9, with improved sensitivity compared to existing methods.
A study published in JAMA Internal Medicine found that people with immune dysfunction, such as HIV infection or rheumatoid arthritis, had a higher rate of COVID-19 breakthrough infections after vaccination. These individuals also experienced worse outcomes compared to those without immune dysfunction.
A clinical trial will harness synthetic chimeric antigen receptor (CAR) T cells to deplete immune B cells and plasma cells producing donor-specific antibodies, aiming to achieve a compatible kidney match for patients with pre-existing antibodies. The NIH-funded study, led by Penn Medicine, intends to begin enrolling patients in 2022.
A recent study published in CJASN found that patients who undergo retransplantation after a failed first kidney transplant have a longer average survival time compared to those on dialysis. The study analyzed data from 2,346 adults and showed that retransplantation resulted in an additional 5.8 months of life expectancy.
Despite receiving three vaccinations, kidney transplant patients have inadequate cellular and humoral protection against SARS-CoV-2, with around 90% showing little to no protection. Researchers are now investigating the efficacy and safety of a human antibody cocktail in these patients.
Researchers at NYU Langone Health have successfully performed their second xenotransplantation procedure using a genetically engineered pig kidney. The procedure, part of an ongoing study, demonstrates continued promise for these genetically engineered organs as a renewable source of life-saving gifts.
The research team aims to increase organ-transplant access for underserved minority patients by developing an integrated dynamic stochastic simulation-optimization model. This model will help patients decide whether to accept a less compatible kidney or wait for a more compatible one.
A study in Ontario, Canada found that in-person requests with physician involvement and trained donation coordinators significantly increase organ donation consent rates. Factors such as age, religion, and neighbourhood income also impact consent decisions.
Researchers identified molecular targets of transplant rejection and developed a laboratory procedure to quantify donor-reactive T cells in mice. The study's findings could lead to improved immune monitoring of clinical transplant recipients and potentially replace invasive procedures like biopsies.
A study at the University of São Paulo found that Torquetenovirus (TTV) titer is higher in people infected by SARS-CoV-2, suggesting it could be a biomarker for COVID-19 severity. TTV load correlates with disease progression and outcome, and its measurement may support diagnosis.
During the pandemic, registrations for alcoholic hepatitis and deceased donor liver transplants increased by over 50%, associated with rising alcohol sales. Alcoholic hepatitis can lead to permanent scarring and long-term damage if left untreated, highlighting the need for public health interventions around excessive alcohol consumption.
A team led by NYU Langone's Robert Montgomery successfully transplanted a genetically engineered pig kidney into a human body, marking a major step forward in xenotransplantation. The procedure, performed on September 25, 2021, used a GalSafeTM pig with the alpha-gal biomolecule removed to avoid rejection.
A new four-year study identifies appropriate ethical and policy guidance for translational xenotransplantation kidney clinical trials. The research team will develop recommendations and decision aids for transplant candidates, clinicians, and institutional review boards reviewing xenotransplantation protocols.
A national review of nocardia infection in kidney transplant patients found that those with compromised immune responses are more vulnerable to the opportunistic agent. Nocardiosis can lead to pneumonia and brain abscess, and screening is crucial, especially in combination with pneumonia symptoms.
Researchers identified specific mesenchymal stromal cells within the bronchovascular bundle of lungs that play a crucial role in creating scarring through interaction with epithelial cells. These cells are thought to be triggered by immune cell attacks, leading to fibrotic scarring and rejection.
A new locally acting treatment aims to reduce the severity of post-transplant ischemia reperfusion injury (IRI) without affecting the immune system. The treatment targets specific neoepitopes exposed on injured donor organs, reducing the risk of organ rejection and improving transplant outcomes.
Researchers found that liver transplant recipients who contracted COVID-19 recovered faster and with less severe inflammation compared to heart or kidney recipients. The study suggests testing certain immunosuppressants to treat COVID-19 patients, regardless of their transplant status.
Pediatric transplant recipients have a more robust immune response to COVID-19 vaccines, achieving higher antibody levels after two doses compared to adult counterparts. This study suggests that the standard two-dose regimen may be safe and effective in pediatric transplant recipients.
A study by Brigham and Women's Hospital researchers found that higher-rated dialysis centers have a 47% higher likelihood of patients being listed for kidney transplantation. The integration of waitlisting rates into quality metrics aims to incentivize greater referral rates and improve facility quality.
Researchers propose reinstating waiting time for recipients experiencing early post-transplant allograft failure within an expanded timeframe to boost transplant numbers. This policy change could potentially reduce the perceived patient-level risk of transplanting marginal organs and improve organ utilization.
Children who receive living donor liver tissue for transplants have nearly twice the survival rate and reduced risk of organ rejection compared to those receiving deceased donor livers. Living donation also shortens wait times for pediatric patients.
A recent study published in CANCER found that cancer significantly reduces the life expectancy of transplant recipients, particularly those who receive lung or heart transplants. The average lifespan lost due to cancer diagnosis among these patients is approximately 2.7 years.
A study published in the American Journal of Transplantation found that Covid-19 vaccines stimulate different immune responses in organ transplant patients. While antibody tests alone are insufficient, combining vaccines with T cell analyses provides better protection.
A new global study found a significant decline in solid organ transplants performed during the first wave of Covid-19 in 2020, with over 48,000 years of patient life lost. Kidney transplantation showed the largest reduction across nearly all countries.
A study of 20,304 kidney transplants found that black recipients and patients receiving kidneys from Asian donors had a higher risk of graft failure within seven years. The study suggests that improved access to organ donation among ethnic minority groups can improve long-term outcomes for all recipients.
A new approach called an immunobiological algorithm provides a comprehensive assessment of how a patient's immune system will react to tissue from each potential living donor. This method outperforms current HLA testing in identifying the best potential living donor, which could lead to improved organ transplant outcomes.
Ongoing acute kidney injury in deceased donor kidneys is linked to lower long-term graft survival. Notably, abnormal serum creatinine values during procurement also negatively impact graft outcomes.
Two studies report substantial reductions in COVID-19 infections and deaths among vaccinated organ transplant patients, with a lower risk of breakthrough infections compared to the general population. Vaccination is considered critically important for this high-risk group.
A new study found Black liver transplant recipients have lower survival rates than white or Hispanic patients, despite interventions aimed at narrowing the gap. The biggest factors contributing to this disparity are alcohol-associated liver disease and insurance type, with Black recipients being more likely to have Medicaid coverage.
The NIH has launched a pilot study to assess the antibody response of kidney transplant recipients to a third dose of an mRNA COVID-19 vaccine. The trial aims to determine if a third dose can overcome the immune suppression caused by lifelong immunosuppressive therapy in this population.
Researchers have developed a special polymer to coat blood vessels on transplanted organs, reducing rejection rates in mice by substantially diminishing immune system response. The breakthrough has the potential to eliminate the need for drugs that prevent organ rejection and improve transplant outcomes.
A recent study published in Transplant Infectious Disease found that COVID-19 vaccination provides strong protection against the virus for solid organ transplant recipients, with an almost 80% reduction in symptomatic cases. The study examined data from over 2,150 transplant patients and showed that nearly 70% of vaccinated patients re...
The new allocation system could result in reduced access to kidney transplants and longer wait times for patients in South Carolina. Researchers argue that the current system unintentionally worsens inequities and recommend improving access to transplant care.
A study by Elisa Cordero and colleagues identified key clinical indicators to detect COVID-19 in solid organ transplant recipients. These indicators enable personalized therapeutic measures to reduce mortality rates, particularly among older patients with respiratory failure or severe immunosuppression.
Researchers found that a third vaccine dose increased antibody levels against SARS-CoV-2 in transplant recipients more than the standard two-dose regimen. The study suggests booster doses should be investigated for those who are immunocompromised to determine if they can receive COVID-19 vaccines as standard clinical practice.
Scientists at Medical College of Georgia are working on a synthetic version of the HLA-G molecule to protect transplanted kidneys from rejection. They hope this therapy will enable dose reduction of standard immunosuppressive drugs, reducing the risk of infections and other medical problems.
The new system automates the organ donation process for hospital staff, saving time and improving patient care. The collaboration enables the referral of potential donors directly to the OPO without manual calls, enhancing the efficiency of the entire process.
A small study from Mayo Clinic researchers raises concerns that some transplant patients may have a limited immune response after receiving an mRNA COVID-19 vaccine. The study found that infected vaccinated solid organ transplant recipients had a 10 times higher infection rate compared to the general population.